Karen Messer

Professor of Biostatistics

University of California, San Diego

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Karen Messer is a Professor of Biostatistics at the University of California, San Diego, USA. Her research focuses on biostatistical methodologies applied to medical studies, with recent work including algorithms for diabetic kidney disease classification, effects of adenoma detection on colorectal cancer risk, and advancements in imaging techniques for liver disease. She is also involved in clinical trials related to cancer treatments and has contributed to understanding trends in cigarette consumption.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karen Messer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Trends in cigarette consumption across the United States, with projections to 2035.

A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study

Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy

Identification of a Novel Small Molecule That Enhances the Release of Extracellular Vesicles with Immunostimulatory Potency via Induction of Calcium Influx

Imaging Non-alcoholic Fatty Liver Disease Model Using H-1 and F-19 MRI

Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model

A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity

A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma

Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial

Collaborators (5)

John Pierce

Partha Ray

Eric Ahrens

Rebekah White

Samir Gupta

Make your next move.